Biotech · Private company
Frontier Biotechnologies Inc.
Track this companyFree. Adds Frontier Biotechnologies Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- 3BNC117Phase 2 · HIV-1-infectionClinicalTrials.gov · fetched Nov 12, 2026
- 3BNC117 AntibodyPhase 2 · HIV/AIDSClinicalTrials.gov · fetched Nov 12, 2026
- AlbuvirtidePhase 2 · HIV-1-infectionClinicalTrials.gov · fetched Nov 12, 2026
- AlbuvirtidePhase 2 · HIV/AIDSClinicalTrials.gov · fetched Nov 12, 2026
- Baseline ARTPhase 2 · HIV-1-infectionClinicalTrials.gov · fetched Nov 12, 2026
- FB2001Phase 1 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Albuvirtide in Combination With 3BNC117 in Patients With Multi-Drug Resistant (MDR) HIV-1 InfectionPHASE2 · UNKNOWN · started Nov 30, 2021ClinicalTrials.gov NCT04560569 · fetched Nov 12, 2026
- The Safety and Efficacy of FB2001 in Healthy Subjects and Patients With COVID-19 InfectionPHASE1 · COMPLETED · started Mar 17, 2021ClinicalTrials.gov NCT04766931 · fetched Nov 12, 2026
- Albuvirtide and 3BNC117 as Long-Acting Maintenance Therapy in Virologically Suppressed SubjectsPHASE2 · UNKNOWN · started Dec 17, 2018ClinicalTrials.gov NCT03719664 · fetched Nov 12, 2026